Clinical Trial to Assess the Safety and Efficacy of EXG001-307 in Patients With Spinal Muscular Atrophy

Clinical trial NCT06888661 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06888661
Sponsor: Guangzhou Jiayin Biotech Ltd
Status: ENROLLING_BY_INVITATION
Phase: Early Phase 1
Study type: INTERVENTIONAL

Spinal Muscular Atrophy (SMA)

Start date: 2025-03-10
Primary completion: 2026-03-01
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.